CL
Therapeutic Areas
CDR-Life Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Not Disclosed (Platform-derived) | Cancer / Autoimmune Diseases | Phase 1 |
Leadership Team at CDR-Life
KV
Konstantin von Schulthess
Chief Financial Officer & Co-founder
LB
Leonardo Borras
Chief Scientific Officer & Co-founder
DC
Dimitrios Chondros
Chief Medical Officer
RB
Rouven Bingel-Erlenmeyer
Chief Technology Officer & Co-founder
SH
Sarah Holland
Chief Business Officer